Concepedia

Greg Anglin

GA

14

Publications

1.6K

Citations

14

H-Index

1997

Active since

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (Canada)

Greg Anglin is an author at Eli Lilly (United States) specializing in medicine, urology, and pharmacology.

Top concepts

Publications per year

1997–2023

14

Publications

14

Efficacy and Safety of Tadalafil for the Treatment of Erectile Dysfunction: Results of Integrated Analyses

Gerald Brock, Chris G. McMahon, K.K. Chen et al. · The Journal of Urology · 2002 · 540 citations

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial

Hartmut Porst, Harin Padma-Nathan, François Giuliano et al. · Urology · 2003 · 324 citations

, , +2

Effects of Tadalafil on Erectile Dysfunction in Men With Diabetes

Iñigo Sáenz de Tejada, Greg Anglin, James Knight et al. · Diabetes Care · 2002 · 246 citations · Full text

Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer.

Shepherd Fa, Abratt Rp, Hana Anderson et al. · PubMed · 1997 · 100 citations

Effects of once‐weekly dulaglutide on kidney function in patients with type 2 diabetes in phase <scp>II</scp> and <scp>III</scp> clinical trials

Katherine R. Tuttle, T. D. McKinney, Jaime A. Davidson et al. · Diabetes Obesity and Metabolism · 2016 · 65 citations · Full text

Rows per page

1–5 of 14